These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 14597935)

  • 1. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting.
    Böttiger C; Koch W; Lahn C; Mehilli J; von Beckerath N; Schömig A; Kastrati A
    Am Heart J; 2003 Nov; 146(5):855-61. PubMed ID: 14597935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 4G/5G promotor polymorphism of the plasminogen activator inhibitor-1 gene and late lumen loss after coronary stent placement in smoking and nonsmoking patients.
    Ortlepp JR; Hoffmann R; Killian A; Lauscher J; Merkelbach-Brese S; Hanrath P
    Clin Cardiol; 2001 Sep; 24(9):585-91. PubMed ID: 11558839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor-1 and outcome after femoropopliteal angioplasty: analysis of genotype and plasma levels.
    Mlekusch W; Schillinger M; Exner M; Sabeti S; Mannhalter C; Minar E; Wagner O
    Thromb Haemost; 2003 Oct; 90(4):717-23. PubMed ID: 14515194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction.
    Cagliyan CE; Yuregir OO; Balli M; Tekin K; Akilli RE; Bozdogan ST; Turkmen S; Deniz A; Baykan OA; Aslan H; Cayli M
    Coron Artery Dis; 2013 May; 24(3):196-200. PubMed ID: 23283030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAI-1 4G/5G gene polymorphism is associated with angiographic patency in ST-elevation myocardial infarction patients treated with thrombolytic therapy.
    Ozkan B; Cagliyan CE; Elbasan Z; Uysal OK; Kalkan GY; Bozkurt M; Tekin K; Bozdogan ST; Ozalp O; Duran M; Sahin DY; Cayli M
    Coron Artery Dis; 2012 Sep; 23(6):400-3. PubMed ID: 22850480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease.
    Grancha S; Estellés A; Tormo G; Falco C; Gilabert J; España F; Cano A; Segui R; Aznar J
    Thromb Haemost; 1999 Apr; 81(4):516-21. PubMed ID: 10235431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
    van Goor ML; Gómez García E; Leebeek F; Brouwers GJ; Koudstaal P; Dippel D
    Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography.
    Ossei-Gerning N; Mansfield MW; Stickland MH; Wilson IJ; Grant PJ
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):33-7. PubMed ID: 9012634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of PAI-1 4G/5G Polymorphism and Clinical Factors on Coronary Artery Occlusion in Myocardial Infarction.
    Parpugga TK; Tatarunas V; Skipskis V; Kupstyte N; Zaliaduonyte-Peksiene D; Lesauskaite V
    Dis Markers; 2015; 2015():260101. PubMed ID: 26273123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study.
    Burzotta F; Iacoviello L; Di Castelnuovo A; Zamparelli R; D'Orazio A; Amore C; Schiavello R; Donati MB; Maseri A; Possati G; Andreotti F
    J Thromb Thrombolysis; 2003 Dec; 16(3):149-54. PubMed ID: 15087600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
    Fu L; Jin H; Song K; Zhang C; Shen J; Huang Y
    Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
    Matsubara Y; Murata M; Isshiki I; Watanabe R; Zama T; Watanabe G; Watanabe K; Ikeda Y
    Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly.
    Mikkelsson J; Perola M; Wartiovaara U; Peltonen L; Palotie A; Penttilä A; Karhunen PJ
    Thromb Haemost; 2000 Jul; 84(1):78-82. PubMed ID: 10928474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction.
    Anderson JL; Muhlestein JB; Habashi J; Carlquist JF; Bair TL; Elmer SP; Davis BP
    J Am Coll Cardiol; 1999 Nov; 34(6):1778-83. PubMed ID: 10577569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association of the plasminogen activator inhibitor-1 promoter 4G/5G polymorphism with inhibitor level during basal transcription in vitro.
    Zhan M; Zhou Y; Han ZC
    Int J Hematol; 2004 May; 79(4):400-4. PubMed ID: 15218974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAI-I 4G/5G polymorphism and sudden cardiac death in patients with coronary artery disease.
    Anvari A; Schuster E; Gottsauner-Wolf M; Wojta J; Huber K
    Thromb Res; 2001 Jul; 103(2):103-7. PubMed ID: 11457467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia.
    Geishofer G; Binder A; Müller M; Zöhrer B; Resch B; Müller W; Faber J; Finn A; Endler G; Mannhalter C; Zenz W;
    Eur J Pediatr; 2005 Aug; 164(8):486-90. PubMed ID: 15843979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual vein thrombosis and onset of post-thrombotic syndrome: influence of the 4G/5G polymorphism of plasminogen activator inhibitor-1 gene.
    Incalcaterra E; Meli F; Muratori I; Corrado E; Amato C; Canino B; Ferrara F
    Thromb Res; 2014 Mar; 133(3):371-4. PubMed ID: 24485402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.